Christophe Nicot

12PUBLICATIONS
8CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCognitive neuroscienceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 27, 2024
Characterization of HTLV-1 Infectious Molecular Clone Isolated from Patient with HAM/TSP and Immortalization of Human Primary T-Cell Lines.

Marcia Bellon, Pooja Jain, Christophe Nicot

|Sep 28, 2024
Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response.

Julie Joseph, Thomas A Premeaux, Ritesh Tandon

|Jun 14, 2024
The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7.

Marcia Bellon, Chien-Hung Yeh, Xue Tao Bai

|May 25, 2024
Increased H19/miR-675 Expression in Adult T-Cell Leukemia Is Associated with a Unique Notch Signature Pathway.

Marcia Bellon, Christophe Nicot

|Jan 26, 2024
HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation.

Marcia Bellon, Christophe Nicot

|Mar 29, 2022
Clinical significance of FBXW7 loss of function in human cancers.

Jingyi Fan, Marcia Bellon, Mingyi Ju

Pageof 2

Frequent Collaborators

1 joint publications

Thomas A Premeaux

1 joint publications

Ritesh Tandon

1 joint publications

Bobby Brooke Herrera

1 joint publications

Reem Alatrash